Serotonin transporter gene polymorphism and psychiatric disorders in NF1 patients

Am J Med Genet. 2001 Dec 8;105(8):758-60. doi: 10.1002/ajmg.10037.

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal-dominant genetic disease characterized by a broad clinical expression. Comorbid affective disorders, anxiety disorders, and suicide are frequently observed during NF1. The promoter marker (5-HTTLPR) of the serotonin transporter gene (5-HTT) has been shown to be associated with major affective disorders, anxiety-related trait, and more recently with suicidal behavior. This gene is adjacent to the NF1 gene, raising the question of the implication of the 5-HTT gene in the psychiatric comorbidity during NF1. Eighty-eight patients with NF1 and 184 screened controls were typed for the 5-HTTLPR. No deviation from the Hardy-Weinberg equilibrium in patients was observed. In addition, allele and genotype frequencies were similar in the two groups. Our data do not support the implication of the 5-HTT gene in the psychiatric comorbidities of NF1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Carrier Proteins / genetics*
  • DNA / genetics
  • Gene Frequency
  • Genotype
  • Humans
  • Membrane Glycoproteins / genetics*
  • Membrane Transport Proteins*
  • Mental Disorders / complications*
  • Nerve Tissue Proteins*
  • Neurofibromatosis 1 / complications
  • Neurofibromatosis 1 / genetics*
  • Polymorphism, Genetic
  • Serotonin Plasma Membrane Transport Proteins

Substances

  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • DNA